Material
I
mmunoglobulin M is the first Ab isotype produced by all vertebrates after initial Ag encounter (1) . It is present as a membrane-bound form on the surface of B cells and as a secreted form (secreted IgM [sIgM] ) that is mainly found in the blood. sIgM is composed of two classes: natural and immune IgM. Natural IgM, characterized by polyreactivity and low affinity, is found in normal quantities in mice raised under germ-free or specific pathogen-free conditions (2, 3) . Immune IgM is secreted after exposure to specific pathogens.
The study of mice deficient in sIgM (Sm 2/2 ) has provided unexpected insights into its role in diverse processes, ranging from B cell survival to atherosclerosis (3, 4) , as well as in autoimmunity and protection against infection (5) . In addition, Sm 2/2 mice also show increased levels of serum IgA, have elevated humoral immunity to T-dependent (TD) Ag, have an increased propensity to develop IgG autoantibodies and autoimmune disease, and have an expanded population of B-1a cells (6) (7) (8) (9) . Peritoneal B-1a cells and, to a lesser extent, marginal zone (MZ) B cells have been identified as the major sources of natural IgM, with spleen and bone marrow (BM) being the major sites of natural IgM production by B-1 cells (10, 11) . Interestingly, Sm 2/2 mice have increased numbers of both B-1a and MZ B cells, suggesting that B cells sense the presence of sIgM (12) . The mechanisms governing expansion of these populations could be related either to modulation of the antigenic environment by natural IgM or its interaction with specific FcRs on the B cell itself. Indeed, it was recently reported that sIgM enhances BCR signaling and regulates B cell homeostasis in different peripheral compartments (13) . Although several ligands and receptors for IgM have been characterized-C1q (14) , mannose-binding lectin (15) , polymeric Ig receptor (16) , and Fca/mR (17)-a long-postulated FcR specific for pentameric IgM, the FCMR (18, 19) , had proved to be remarkably elusive. Nonetheless, recent elegant studies have provided definitive evidence for the presence of FCMR on human and mouse lymphocytes, and have characterized the genes encoding the proteins (20) (21) (22) . Notably, however, other studies have suggested that this molecule does not bind IgM but instead confers resistance to cell death mediated by TNFR1 and CD95 signaling (23) (24) (25) . A clear definition of the function of the receptor in the biology of normal B cells has not been developed.
In this study, we took advantage of FCMR-deficient (Fcmr 2/2 ) mice to understand the contributions of the receptor to B cell development, differentiation, and function. These experiments identified essential roles played by FCMR in B lymphopoiesis in the BM, the population of mature B cell subsets, responses to TD and T-independent (TI) Ags, signaling through the BCR, and inhibition of autoreactivity. We determine that FCMR is critically involved in multiple aspects of B cell differentiation, homeostasis, and function.
Materials and Methods
Mice and cell line Fcmr 2/2 mice on a C57BL/6 (B6) genetic background were provided by the University Health Network (Toronto, Ontario, Canada). In brief, to generate these mice, we replaced exons 2-8 of the Fcmr gene by a neomycin resistance gene cassette that was assembled using a 7.5-kbp fragment found within an intron located in the 59 leader sequence of the gene and a 0.65-kbp fragment that was synthesized downstream of the last methionine codon in the gene by PCR (Supplemental Fig. 1 ). After electroporating this construct into embryo stem cells, homologous recombinant cells were injected into blastocysts and implanted into pseudopregnant mice. The chimeras produced were bred until germline transmission occurred in the progeny. Mice were analyzed for heterozygosity of the rearranged allele; then heterozygous mice were bred together to obtain homozygosity of the rearranged allele. Sm 2/2 mice (7) were provided by Dr. Troy Randall (University of Rochester). Wild type (+/+) controls were littermates generated by crosses of mutant heterozygotes. Mice were used in this study under protocol LIG-5E approved by the National Institute of Allergy and Infectious Diseases Institutional Animal Care and Use Committee. The human YTS NK cell line and methods used for infection with a control lentivirus or a lentivirus-expressing full-length mouse Fcmr were described previously (20) .
Flow cytometry (FACS)
Single-cell suspensions were prepared from BM of the tibia and femur from one leg, spleen, and peritoneum using standard procedures. After red cell lysis, cells were blocked with anti-CD16/32 Ab (2.4G2) and stained for FACS in 0.5% FBS in PBS. Abs used were to CD3 (145-2C11), CD4 (RM4-5), CD5 (53-7.3), CD8 (53-6.7), CD11b (M1/70), CD11c (N418), CD19 (MB19-1), CD21 (eBio8D9), CD23 (B3B4), CD24 (30-F1), CD43 (eBioR2/ 60), CD138 (281-2), B220 (RA3-6B2), Gr-1 (RB6-8C5), Ly-77 (GL7), NK1.1 (PK136), CD25 (7D4), pre-BCR (SL156), Igk (187.1), BP-1 (6C3), AA4.1 (AA4.1), IgM b (AF6-78), and IgD b (217-170). Data were collected on a FACSort or LSRII (BD Biosciences) and analyzed with FlowJo software (Tree Star). Ab-stained cells were also sorted by a FACSAria (BD Biosciences) with a purity $95%.
RNA isolation and quantitative real-time RT-PCR

Splenic CD4
+ T, CD8 + T, NK, and B cells were purified by negative selection using MACS MicroBeads kits. Splenic Gr-1 + , CD11b + , CD11c + , and BM c-Kit + cells were purified by positive selection using MACS MicroBeads kits. B cell subsets were purified by FACS. Total RNA isolated from purified cells using the RNAquous-4PCR kit (Ambion) was treated with DNase I according to the manufacturer's recommendations. cDNA was synthesized with Qscript cDNA synthesis kit (Quanta Biosciences). Quantitative real-time PCR (qRT-PCR) was performed using Lightcycler 480 SYBR green I master supermix, according to the manufacturer's instructions (Roche Diagnostics). Oligonucleotide primers for amplifying the mouse Fcmr and 18S rRNA were purchased from Qiagen. All reactions were done in triplicate and the average value of triplicates was used for calculating the relative levels of each mRNA species. Relative quantification of Fcmr transcripts was made with the second derivative maximum method using the Roche Lightcycler software and calculating the fold change over 18S rRNA levels.
Testing for antinuclear Ab
Serum antinuclear Abs (ANAs) were detected using 12-well microscope slides covered with HEp-2 cells (Netherlands Foundation for Biological Research). Slides were incubated with mouse serum at the 1/200, 1/500, and 1/1000 dilutions for 30 min at room temperature. After two washes of 5 min with PBS, goat anti-mouse IgG-FITC (Sigma-Aldrich) was added at 1:250 dilutions for 30 min at room temperature and washed with PBS for 5 min at least three times. Fluorescence was detected by fluorescence microscopy at 320 magnification using a Zeiss Axio Imager Upright microscope (Carl Zeiss).
Immunohistochemistry
Splenic paraffin sections were stained for germinal centers (GCs) using biotinylated peanut agglutinin (PNA), streptavidin-HRP, and the diaminobenzidine method. Immunostained sections were scanned at original magnification 320 using a ScanScope XT (Aperio Technologies). Aperio ImageScope (version 11) software was used for digital slide image viewing and analysis. The total area (mm 2 ) was measured for each spleen, and the number of positive pixels for PNA-reactive areas was determined. Specific immunoreactivity (IR) was calculated as the number of positive pixels per square millimeters of spleen tissue.
Immunization and Ab detection
For TI or TD responses, 6-to 8-wk-old mice were immunized i.p. with 20 mg 4-hydroxy-3-nitrophenyl acetyl (NP)-Ficoll, 50 mg NP-LPS, or 100 mg NP-keyhole limpet hemocyanin (NP-KLH; Biosearch Technologies) in alum. Blood samples were taken from each group at 2 wk after TD immunization (NP-KLH) or 1 wk after TI immunization (NP-Ficoll or NP-LPS). For recall responses, mice were challenged with NP-KLH at 12 wk after primary immunization. Sera were collected at 2 and 13 wk after primary immunization. NP-specific Abs were measured by ELISA using NP (27)-BSA (Biosearch Technology) precoated plates, followed by incubation with diluted serum samples, and developed with HRP-conjugated mouseisotype specific Ab (Southern Biotech) and p-nitrophenyl phosphate substrate (MP Biomedical). Serum anti-dsDNA IgG levels were analyzed with a mouse anti-dsDNA IgG-specific ELISA kit (Alpha Diagnostic International). The plates were read at 450 nm using an ELISA plate reader. 
Reconstitution and serum transfer
Lethally irradiated (5 Gy) Rag1 2/2 mice were reconstituted i.v. 1 d later with 2 3 10 5 hematopoietic stem cells (HSCs) purified from BM cells of 2-mo-old +/+ and Fcmr 2/2 mice using lineage cell depletion kits (Miltenyi Biotec). After 2 wk, 100 ml sera collected from 2-mo-old B6 and Sm 2/2 mice were injected i.v. three times per week for 2 wk. BM cells were harvested and B cell subpopulations were analyzed by FACS.
Assays for cell proliferation and apoptosis
Splenic B cells were purified by negative selection using a MACS MicroBeads kit (Miltenyi Biotec), according to the manufacturer's instructions. For in vitro B cell proliferation assays, cells seeded at 2 3 10 5 cells/well were cultured in 96-well flat-bottom plates with LPS (1 mg/ml; Sigma), CpG-DNA (2.5 mg/ml; InvivoGen), anti-CD40 mAb (1 mg/ml; Alexis), recombinant mouse IL-4 (10 ng/ml; R&D Systems), or F(ab9) 2 anti-mouse IgM Ab (10 mg/ml; Jackson Immunoresearch Laboratory) for 3 d. Cells were pulsed with 1 mCi [ 3 H]thymidine for the last 16 h of culture, and incorporation was measured by liquid scintillation counting.
For analyses of apoptosis, purified B cells seeded at 5 3 10 5 cells/well in 24-well plates were stimulated with LPS, anti-CD40 mAb, or F(ab9) 2 antimouse IgM Ab for 24 h. Cells were then stained with Annexin V (BD Biosciences) and 7-aminoactinomycin D (7-AAD; eBioscience) for FACS analysis.
Statistical analysis
Significance of differences between groups was evaluated by Student t test. A p value ,0.05 was considered significant.
Results
Fcmr is highly expressed by B lineage cells
Previous studies using qRT-PCR and flow cytometry indicated that Fcmr, the gene encoding FCMR, is expressed primarily by cells of the adaptive immune system (20, 21, 24) . Because there is no commercially available source of Abs to FCMR to study cellsurface protein expression, we extended these analyses by using qRT-PCR to quantify Fcmr transcript levels in purified subpopulations of hematopoietic cells from spleen, peritoneum, and BM. Splenic CD4 + and CD8 + T cells expressed very low levels of Fcmr transcripts with slightly higher levels in NK cells, whereas expression in B cells was 500-fold higher than in T cells. Transcripts in follicular (FO) B cells were 2-fold higher than in MZ B cells, whereas expression in GC B cells and plasma cells (PCs) was markedly lower (Fig. 1B) . Transcript levels in peritoneal B-1 and B-2 cells were comparable with those of MZ B cells (Fig. 1C ). These findings indicate that FCMR is differentially expressed in distinct subsets of mature peripheral B cells and may differentially affect their functions. The finding of high levels of Fcmr transcripts in peripheral B cells prompted us to investigate whether differing levels of expression were associated with progression of B cell development in the BM. Studies of sort-purified B lineage subsets demonstrated that transcript levels in pro-B and pre-B cells were low but were significantly higher in more differentiated immature B cells (Fig. 1D) , suggesting that FCMR influences early B cell development.
Studies of splenic myeloid cells revealed low levels of transcripts in CD11b
+ macrophages with higher levels in CD11c + dendritic cells (DCs) and Gr-1 + granulocytes (Fig. 1A) . Parallel studies of BM cells (Fig. 1A ) revealed only very low levels of transcripts among BM-derived DCs and by c-Kit + cells that include HSCs, multipotent progenitors, common myeloid progenitors, and common lymphoid progenitors. were significantly higher for Fcmr 2/2 mice. Although numbers of B-1b cells were similar for both sets of mice, the numbers of B-1a cells were significantly higher and the numbers of B-2 cells were significantly lower for Fcmr 2/2 mice.
Interestingly, the patterns of B cell development and distribution of peripheral B cell subsets seen with Fcmr 2/2 mice had many similarities to those reported for two strains of mice deficient in sIgM (Sm 2/2 mice) (6, 7, 9) . The fact that both knockout strains were generated using 129 ES cells and were studied at different ages as F2 (7, 9) than +/+ mice (Supplemental Fig. 2 ). These results suggest that much of the Sm 2/2 B cell phenotype can be ascribed to the absence of FCMR-sIgM receptor-ligand interactions. We conclude that expression of FCMR significantly influences pre-B and immature B cell development in the BM and the distribution of mature B cells into distinct subsets in the spleen and peritoneum, and suggest that these effects are mediated, in large part, by binding of sIgM.
We also quantified basal levels of serum Ig isotypes of 3-and 6-mo-old +/+ and Fcmr 2/2 mice (Fig. 3A) . For 3-mo-old mice, the levels of serum IgM, IgA, and all IgG isotypes except IgG1 (lower in Fcmr 2/2 mice) were similar for both sets of mice. For 6-mo-old mice, the levels of both IgG3 and IgA were increased in sera from Fcmr 2/2 mice, whereas levels of the other isotypes were comparable between the cohorts. The increased levels of IgG3 and IgA in sera of 6-mo-old Fcmr 2/2 mice could reflect the increased numbers of B-1a cells that characterize the strain (Fig. 2C) . The increased serum levels of IgG3 in Fcmr 2/2 mice and the prior demonstration (Fig. 3B) . Serum ANAs giving a diffuse staining pattern were present in sera from three of seven 6-mo-old Fcmr 2/2 mice (Fig. 3C ), but none of seven +/+ age-matched con- trols. We conclude that FCMR may negatively regulate autoimmunity by functioning as a receptor for sIgM.
Early B cell development is affected by FCMR and sIgM
The reduced numbers of pre-B cells in Fcmr 2/2 mice prompted us to examine whether certain B cell-intrinsic or -extrinsic mechanisms might contribute to this effect. The transcription factor PAX5 was selected as one candidate because it regulates the expression of a number of genes encoding proteins that promote B cell differentiation (26) . However, qRT-PCR analyses of Pax5 transcript levels showed that they were equivalent for both cohorts in sorted early B cell populations of increasing maturity (data not shown BM cells (Fig. 4A) . The frequencies of pre-B cells expressing CD25 or the pre-BCR were also equivalent between +/+ and Fcmr 2/2 mice (Fig. 4A) . mice. This allowed us to evaluate the effect of sIgM on early B cell The Journal of Immunologydevelopment. As shown in Fig. 4B , recipients of +/+ HSCs and sIgM + sera generated significantly more pre-B cells than recipients of +/+ HSCs and sIgM 2 sera. The numbers of immature B cells also tended to be higher in recipients of sIgM + sera than those receiving sIgM 2 sera. As expected, the presence or absence of sIgM in sera given to recipients of Fcmr 2/2 HSCs had no effect on the generation of pre-B cells. From this, we conclude that FCMR functions as a gatekeeper controlling pre-B and immature B cell development, and that binding of sIgM to the receptor has a positive effect on development of these cells. These results are fully consistent with the observations that natural IgM influences B cell development and survival (3, 6, 13) . To more rigorously examine the suggested associations between sIgM and FCMR, we incubated the human YTS cell line expressing full-length mouse FCMR with pentameric mouse IgM in serum-free medium. The results showed clear binding of IgM to the transfected line (Supplemental Fig. 3 ), strongly supporting earlier reports of receptor-ligand interactions between FCMR and IgM on both mouse and human cells (20, 22) . We next asked whether FCMR might influence the development of humoral immune responses to either TI or TD Ags by assessing GC development, the generation of total PCs, as well as Ag-specific cells in spleen and BM, and the levels of Ag-specific IgM in sera of immunized mice. We first studied responses to the TI type I Ag, NP-LPS, and the TI type II Ag, NP-Ficoll. TI Ags have been shown to generate short-lived GCs that fail to engage in somatic hypermutation and affinity maturation (28, 29) , whereas still leading to the generation of long-lived PCs in spleen and BM (30) . At 1 wk after immunization with either TI Ag, the total numbers of splenic GC B cells (PNA hi GL7 hi ) were higher for Fcmr 2/2 than for +/+ mice (Fig. 5A ). In addition, the numbers of splenic PCs, including fully mature CD138 + B220 2 PCs and CD138 + B220 + plasmablasts, were significantly higher for Fcmr 2/2 mice than their +/+ counterparts (Fig. 5A) . Ag-specific, IgM-secreting cells in the spleen and BM were analyzed by ELISPOT, and serum NP-specific IgM Abs were measured by ELISA. After immunization with NP-LPS, the numbers of NP-specific, IgM-secreting cells in both the spleen and BM, and the levels of NP-specific serum IgM were significantly higher for Fcmr 2/2 than +/+ mice (Fig. 5B, 5C ). This result is in keeping with the increased numbers of B-1a cells in Fcmr
mice that dominate responses to TI type I Ags. Parallel studies of mice immunized with NP-Ficoll showed that the numbers of Agspecific splenic PCs and levels of NP-specific serum IgM were similar for mice of both genotypes, although the frequencies of Ag-specific PCs were significantly higher in the BM of Fcmr 2/2 than +/+ mice (Fig. 5B, 5C ). These data are consistent with the observation that the numbers of MZ B cells, which are primarily responsible for responses to TI type II Ags, are comparable in FCMR-deficient and +/+ mice.
We next examined the responses of +/+ and Fcmr 2/2 mice to immunization with the TD Ag, NP-KLH, in alum. Two weeks after immunization, the total numbers of splenic PCs were significantly higher in Fcmr 2/2 than +/+ mice, even though the numbers of GC B cells were comparable for mice of both genotypes (Fig. 5D) . ELISPOT analyses showed that the numbers of Agspecific IgM-secreting PCs were ∼40% higher in spleens of Fcmr 2/2 mice but comparable in the BM. However, studies of NP-specific IgG1-secreting cells showed that their numbers were comparable in spleens of mice of both genotypes but were lower in the BMs of Fcmr 2/2 mice (Fig. 5E) . Analyses of NP-specific serum Igs showed that the levels of IgM Ab were higher and the levels of IgG2b were lower for Fcmr 2/2 mice, whereas the levels of the other isotypes were comparable (Fig. 5F ). Taken together, these results suggest that FCMR negatively regulates humoral immune responses against both TI and TD Ags.
Secondary responses to TD Ags by Fcmr 2/2 mice
We next examined the secondary responses of +/+ and Fcmr
2/2
mice to NP-KLH. The mice were boosted 12 wk after a primary immunization and assayed 1 wk later for PCs and serum Abs. The numbers of splenic PCs detected by flow cytometry were significantly higher for Fcmr 2/2 than +/+ mice (Fig. 6A) , similar to what was observed in the primary response. In contrast with the primary response, however, the numbers of GC B cells assessed by FACS (Fig. 6B) or by quantitative immunohistochemistry (Fig.  6C) were significantly higher for FCMR-deficient than +/+ mice. ELISPOT analyses of cells secreting NP-specific Ab showed that the numbers of cells producing IgM in spleen or BM were similar for mice of both genotypes. However, the numbers of IgG1-producing cells were increased in the spleen and somewhat in the BM of Fcmr 2/2 mice (Fig. 6D ), suggesting that FCMR had a negative influence on class-switch recombination in this secondary response.
Analyses of NP-specific serum Abs revealed that except for IgG3, the levels for other isotypes were similar for mice of both genotypes at 1 wk after the boost. However, similar to the previous study (Fig. 5F ), there were small but significant differences in IgM and IgG2b levels after primary immunization (Fig. 6E) . Thus, although the numbers of GC B cells and PCs were increased in Fcmr 2/2 mice after a secondary challenge with NP-KLH, the production of Ag-specific Ab was not significantly increased, arguing against a major role for FCMR during a recall response.
FCMR influences B cell proliferation and survival, but not BCR ligation-induced signaling
To examine the biological functions of FCMR, we tested splenic B cells from +/+ and Fcmr 2/2 mice for their ability to proliferate and undergo cell death upon activation in vitro. We found that transcript levels for Fcmr were markedly reduced after stimulation of purified B cells with LPS or anti-CD40, as well as after BCR ligation with anti-IgM Ab (Fig. 7A) . Proliferative responses to stimulation by LPS, CpG, and anti-CD40 Ab by B cells from both cohorts of mice were similar (Fig. 7B) . In contrast, the response of cells from Fcmr 2/2 mice to BCR ligation with F(ab9) 2 anti-IgM
Ab was significantly reduced in a dose-dependent manner (Fig.  7B, 7C ). Parallel studies of cell viability showed that survival of B cells from Fcmr 2/2 and +/+ mice was the same after treatment with LPS or anti-CD40 Ab, but that the viability of cells from Fcmr 2/2 mice after BCR cross-linking was significantly reduced (Fig. 7D) . Thus, FCMR appears to promote B cell proliferation, as well as protect against apoptosis after BCR ligation.
Discussion
The results of this study demonstrate that FCMR plays a role in B cell differentiation, function, and homeostasis. Mice deficient in FCMR exhibit multiple alterations in early B cell development, the distribution of mature B cell subsets, responses to antigenic challenge, and are predisposed to autoimmunity. The fact that many of these changes mirror those observed in mice lacking sIgM indicates that FCMR is a critical sensor of circulating IgM and provides a basis for understanding a number of its functions in health and disease. ond, it is unclear whether FCMR-triggered signaling requires engagement with soluble IgM. However, our analyses of Sm (Fig. 4B) . Because a previous study of Sm 2/2 mice (7) did not identify defects in early B cells like those seen in our analyses of Fcmr 2/2 mice, the nature of FCMR-mediated signaling requires further investigation. Analyses of the effects of FCMR deficiency on subsets of mature B cells revealed two contrasting pictures, with the numbers of splenic FO B cells being significantly reduced, whereas the numbers of peritoneal B-1a cells were significantly increased. Remarkably, these observations again mirror those made in sIgMdeficient mice (13) implicating FCMR-sIgM interactions as critical to both phenotypes. FO B cells, similar to resting small pre-B cells, are not in cell cycle and they differentiate with minimal signaling from the BCR (36) . The lack of FCMR-augmented tonic signaling might reduce the level of FO BCR signaling below the threshold required for survival, whereas also enhancing their apoptotic response to BCR ligation. This concept is in keeping with the known importance of tonic signaling for B cell survival demonstrated in studies of Cre-mediated ablation of BCRs in mature B cells (37, 38) and in mice expressing engineered BCRs without extracellular domains (36, 39) . It would also be consistent with the observation that Sm 2/2 mice, which are unable to activate the FCMR, have more apoptotic splenic B cells (13) . The contrasting increase in peritoneal B-1a cells in FCMRdeficient mice may relate to the greater intensity of BCR signaling associated with their selection and survival than occurs with FO B cells (40, 41) and is associated with their anergic phenotype (42) . As suggested by Ehrenstein and Notley (3) from studies of sIgM-deficient mice, this strength of signaling may poise B-1a B cells at the threshold for apoptosis such that a reduction in tonic signaling would promote their survival and the observed increases in cell numbers.
The known contribution of natural IgM to complementdependent clearance of apoptotic cells (43) provides a basis for understanding how expanded populations of B-1a cells, as a source of sIgM, could predispose mice lacking FCMR to autoimmunity. Sera from 6-mo-old Fcmr 2/2 mice had significantly increased levels of IgG anti-DNA Abs, and sera from nearly half of these mice were positive for ANAs with staining patterns characteristic for Abs to dsDNA or histones. Interestingly, our studies of Fcmr 2/2 mice identified enhanced IgM responses to TD Ags (Fig. 5) , arguing for a negative rather than a positive regulatory effect on TD immune responses. Nonetheless, IgG responses to TD Ags were not similarly enhanced; indeed, IgG2b production was significantly decreased in Fcmr 2/2 mice.
The lack of enhanced class switching in Fcmr 2/2 mice is associated with reduced expression of Fcmr by GC B cells and PCs (Fig. 1) . It is worth noting that the observed changes in TD immune responses by FCMR-deficient mice could be influenced by other cell types lacking FCMR and/or expression of the FCAMR that was previously shown to influence responses to different Ags (31) . Given the abundance of natural IgM Abs and the broad expression of FCMR, we envision that this receptor could play important roles in innate immunity. IgM immune complexes aggregated by FCMR at the cell surface are readily internalized and transported through the endocytic pathway to lysosomes where they are degraded (46) . Engagement of this pathway to dispose of IgM-bound pathogens and extracellular debris could result in synergistic activation of B cells stimulated through their BCRs (47 (48) . The identification of FCMR as a receptor for sIgM, supported by results presented in this article, need not be an either/or proposition regarding its role in apoptosis. Indeed, our studies suggest a protective role against cell death after BCR ligation of splenic B cells and possibly during early B cell development as well. Understanding how these differing potentials might play out in the biology of individual cells will certainly be a focus of future studies.
In conclusion, the development and function of B cells in FCMR-deficient mice is remarkably similar to that of Sm 2/2 mice, highlighting critical roles for the sIgM-FCMR axis in regulating normal B cell differentiation, modulating innate and adaptive immunity, and protecting against the development of humoral autoimmunity. Further studies are required to characterize the molecular features of FCMR-triggered signaling and its contributions to these differing phenotypes. 
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